Last reviewed · How we verify
NCT05551364
Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy
NA trial testing ATLAS 2030 exoskeleton in Cerebral Palsy in 30 participants. Completed in 30 August 2023.
2 June 2023
Quick facts
| Lead sponsor | MarsiBionics |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 5 September 2022 |
| Primary completion | 2 June 2023 |
| Estimated completion | 30 August 2023 |
| Sites | 6 locations across Spain |
Drugs / interventions tested
- ATLAS 2030 exoskeleton
Conditions studied
- Cerebral Palsy — all drugs for Cerebral Palsy →
Sponsor
MarsiBionics
Who can join
Adults 3 to 14, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective of this study is to assess the usability and efficacy of receiving therapy with the peaditric exoskeleton ATLAS 2030in children with gait impairment due to a cerebral palsy condition. It will be valued the impact of rehabilitation with the exoskeleton at the physical level on parameters such as joint range, spasticity, as well as the impact in quality of life. It is also assessed the impact at the level of functionality of the participants, through the administration of different functional assessment scales.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Benefits of robotic gait assistance with ATLAS 2030 in children with cerebral palsy.
Castro P, Martí M, Oliván-Blázquez B, Boñar N, et al · · 2024 · cited 2× · PMID 39135857 · DOI 10.3389/fped.2024.1398044
Verify or expand the search:
- PubMed search for NCT05551364
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cerebral Palsy
Currently open trials in the same condition.
- NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
- NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
- NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
- NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
- NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting
Other MarsiBionics trials
Trials by the same sponsor.
- NCT07159360 — Safety, Usability, and Effectiveness of a Gait Exoskeleton for Children and Adolescents With Neurodevelopmental Disorder · NA · not yet recruiting
- NCT06894160 — Safety and Usability of the EXPLORER Exoskeleton in Adults With Neuromuscular Diseases · NA · not yet recruiting
- NCT06765070 — Efficacy and Usability of the EXPLORER Exoskeleton in Children With Neurodevelopmental Disorders in Natural Environments · NA · active not recruiting
- NCT06167954 — Safety and Usability of a Robotic Gait Device for Children and Adolescents With Neurological or Neuromuscular Disease in · NA · completed
- NCT05926635 — Efficacy of a Rehabilitation Program With the Pediatric Exoskeleton ATLAS 2030 in Pediatric Patients With Cerebral Palsy · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05551364 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by MarsiBionics
- Last refreshed: 27 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05551364.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing